期刊文献+

禽大肠埃希菌耐药谱及氨基糖苷耐药基因分子流行病学调查 被引量:6

Antibiotics resistance and molecular epidemiology of aminoglycoside resistant gene in avian pathogenic E.coli
下载PDF
导出
摘要 为了明确禽大肠埃希菌的耐药情况和氨基糖苷抗性基因的流行情况,用K-B纸片扩散法检测了27株致病性大肠杆菌对19种常用抗生素的耐药谱,用PCR方法检测了耐氨基糖苷抗生素分离株的4种氨基糖苷抗性基因,包括腺苷转移酶基因aadA1和aadB、乙酰转移酶基因aacA4和磷酸转移酶基因apH(3′)-Ⅱ。结果表明,氨苄青霉素、安灭菌、青霉素G和四环素的耐药菌株率高达100%,利福平的耐药菌株率达96.3%,氯霉素、红霉素的耐药菌株为70.4%,卡那霉素、环丙沙星、氟哌酸的耐药菌株率为59.3%,链霉素的耐药菌株达到63.0%。氨苄西林/舒巴坦复方制剂、复达欣、庆大霉素和磷霉素的高敏菌株率分别为100%、77.8%、74.1%和51.9%。氨基糖苷抗性基因aadA1、aacA4和apH(3′)-Ⅱ的阳性率分别是44.4%、27.8%和55.6%,aadB未捡出。这些数据提示禽致病性大肠埃希菌存在广泛的耐药谱,氨基糖苷抗性基因aadA1和apH-(3′)-Ⅱ是主要流行基因。 In order to investigate the patterns of antibiotic resistance and prevalence of aminoglycoside resistant genes in pathogenic E. coli isolated from poultry, K-B disk diffusion method was used to detect the susceptibility of 27 E. coli isolates to 19 kinds of antimicrobial agents, and 4 aminoglycoside resistant genes of aminoglycoside adenyltransferases aadA1 and aadB, aminoglycoside phosphorylases apH (3')-Ⅱ and aminoglycoside acetyltransferases aac A4 were detected by using PCR. Results indicated that the resistance strains of 27 isolates to ampicillin,amoxicillin,penicillin G and tetracin were 100%, and that to rifampicin, chloromycin, erythromycin, Kanamycin, ciproftoxacin, norfloxacin and :Streptomycin were 96. 3%, 70.4%, 70.4%, 59.26%, 59.3%, 59.3%, and 63.0%, respectively. The percentage of sensitive E. coli isolates to Ampicillin/sulbactan, Fortum, Gentamicin and Fosfomycin were 100%, 77. 8%, 74. 1% and 51.9%, respectively. PCR results showed that 44.4%,27.8% and 55.6% of the tested isolates were positive for aadAl,aacA4 and apH(3P)- Ⅱ ,respectively. The aadB gene was not detected. These data showed that the spectrum of drug-resistance of avian pathogenic E. coli was very broad, and the aminoglycoside resistance gene of apH(3')-Ⅱ and aadA1 were leading prevalence genes.
出处 《中国兽医杂志》 CAS 北大核心 2009年第6期6-8,共3页 Chinese Journal of Veterinary Medicine
关键词 大肠埃希菌 耐药谱 氨基糖苷耐药基因 流行病学 E. coli spectrum of drug-resistance aminoglycocide resistant gene epidemiology
  • 相关文献

参考文献8

  • 1Kotra L P, Haddad J, Mobashery S. Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance [J]. Antimicrobial Agents and Chemotherapy, 2000, 44, 3249-3256.
  • 2Miller G H, Sabatelli F J, Hare R S, et al. The most frequent aminoglycoside resistance mechanisms-changes with time and geographic area : a reflection of aminoglycoside usage patterns? [J].Clinical Infectious Diseases, 1997, 24 (1) : 46-62.
  • 3Quintilianir J R, Sahm D F, Courvalin P. Mechanisms of resistance to antimicrobial agents [M]// Manual of Clinical Microbiology. Murray P R, Baron E J, Pfaller M A, et al. Washington DC: American Society for Microbiology, 1999: 1505-1525.
  • 4Davies J, Wright G D. Bacterial resistance to aminoglycoside antibiotics [J]. Trends in Microbiology, 1997, 5: 234-240.
  • 5申阿东,张桂荣,王咏红,杨永弘.B组链球菌的耐药性及红霉素耐药基因检测研究[J].中华儿科杂志,2005,43(9):661-664. 被引量:15
  • 6萨姆布鲁克J,拉塞尔DW.分子克隆指南[M].黄培堂,王嘉玺,朱厚础,等译.3版.北京:科学出版社,2002.
  • 7李兴禄,黄长武,马珺.产气肠杆菌、阴沟肠杆菌、沙雷菌AmpC酶检测及耐药性分析[J].重庆医学,2003,32(3):303-305. 被引量:10
  • 8Tenover F C, Hughes J M. The challenges of emerging infectious diseases: Development and spread of multiply-resistant bacterial pathogens[J].JAMA, 1996,275 : 300-304.

二级参考文献22

  • 1徐英春,陈民钧.AmpC酶与革兰阴性菌的耐药特征[J].中华微生物学和免疫学杂志,2001,21(S1):18-20. 被引量:24
  • 2American College of Obstetricians and Gynecologists. Prevention of early-onset group B streptococcal disease in newborns. Int J Gynaecol Obstet,2003,81:115-122.
  • 3Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Recomm Rep,1996,45(RR-7):1-24.
  • 4Andrews JI, Diekema DJ, Hunter SK, et al. Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. Am J Obstet Gynecol,2000,183:859-862.
  • 5Betriu C, Culebras E, Gomez M, et al. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob Agents Chemother, 2003,47:1112-1114.
  • 6Uh Y, Jang IH, Hwang GY. Emerging erythromycin resistance among group B streptococci in Korea. Eur J Clin Microbiol Infect Dis, 2001,20:52-54.
  • 7Morikawa Y, Kitazato M, Katsukawa C, et al. Prevalence of cefotaxime resistance in group B streptococcus isolates from Osaka, Japan. J Infect Chemother, 2003,9:131-133.
  • 8Ko WC, Lee HC, Wang LR, et al. Serotyping and antimicrobial susceptibility of group B Streptococcus over an eight-year period in southern Taiwan. Eur J Clin Microbiol Infect Dis,2001,20:334-339.
  • 9Rouse DJ, Andrews WW, Lin FY, et al. Antibiotic susceptibility profile of group B streptococcus acquired vertically. Obstet Gynecol,1998,92:931-934.
  • 10Croak A, Abate G, Goodrum K, et al. Predominance of serotype V and frequency of erythromycin resistance in Streptococcus agalactiae in Ohio. Am J Obstet Gynecol,2003,188:1148-1150.

共引文献24

同被引文献112

引证文献6

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部